Treatment for relapsed/refractory sickness must be determined determined by prior therapy in addition to The main reason why the initial procedure was no longer proper (e.g., refractoriness vs. intolerance). Ibrutinib is the current gold common therapy for people with relapsed/refractory disorder, dependant on the results of a number of section I-I